megan manzari: Live & Latest News Updates : Vimarsana.com

Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model

Myriad Genetics Patient Outcomes Study Shows RiskScore

Myriad’s MyRisk™ Hereditary Cancer test with RiskScore® provides a personalized breast cancer risk assessment for women of all ancestries...

GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care

GeneSight Mental Health Monitor Reveals Gap on the Front

Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care...

Myriad Genetics (MYGN) Announces UroSuite

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

SALT LAKE CITY, Nov. 03, 2022 -- Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced today JCO Precision Oncology has published a study1 that highlights the... | November 3, 2022

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

Stock Market | FinancialContent Business Page

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

03.11.2022 - SALT LAKE CITY, Nov. 03, 2022 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced today JCO Precision Oncology has published a study1 that highlights the development and ...

New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients | Comunicados | Edición USA